Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) had its price objective increased by Truist Financial from $10.00 to $13.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has a "hold" rating on the pharmacy operator's stock. Truist Financial's price target suggests a potential upside of 3.83% from the company's previous close.
WBA has been the topic of a number of other reports. TD Cowen dropped their price objective on Walgreens Boots Alliance from $16.00 to $14.00 and set a "buy" rating on the stock in a research note on Tuesday, October 22nd. Royal Bank of Canada increased their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a "sector perform" rating in a research report on Wednesday. Morgan Stanley decreased their target price on Walgreens Boots Alliance from $9.00 to $7.00 and set an "underweight" rating for the company in a research report on Friday, October 11th. Bank of America increased their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a report on Monday. Finally, UBS Group upped their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a "neutral" rating in a research report on Thursday, October 17th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $13.27.
Read Our Latest Stock Analysis on Walgreens Boots Alliance
Walgreens Boots Alliance Trading Down 3.2 %
Shares of WBA stock traded down $0.41 during mid-day trading on Thursday, reaching $12.52. 33,936,559 shares of the stock traded hands, compared to its average volume of 31,410,309. The stock's fifty day simple moving average is $9.50 and its two-hundred day simple moving average is $9.85. The company has a market cap of $10.81 billion, a price-to-earnings ratio of -1.22, a price-to-earnings-growth ratio of 1.55 and a beta of 0.64. Walgreens Boots Alliance has a 1-year low of $8.08 and a 1-year high of $23.76. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion during the quarter, compared to analysts' expectations of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. Walgreens Boots Alliance's revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period in the prior year, the company posted $0.66 earnings per share. On average, research analysts anticipate that Walgreens Boots Alliance will post 1.52 EPS for the current fiscal year.
Institutional Investors Weigh In On Walgreens Boots Alliance
Hedge funds have recently made changes to their positions in the business. First Financial Corp IN raised its holdings in shares of Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock worth $25,000 after purchasing an additional 885 shares during the period. TD Private Client Wealth LLC boosted its position in shares of Walgreens Boots Alliance by 8,670.3% in the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator's stock valued at $29,000 after acquiring an additional 3,208 shares during the period. Sentry Investment Management LLC purchased a new position in Walgreens Boots Alliance during the third quarter valued at approximately $30,000. Eastern Bank purchased a new stake in Walgreens Boots Alliance in the 3rd quarter worth approximately $33,000. Finally, Strategic Investment Solutions Inc. IL bought a new position in Walgreens Boots Alliance in the 2nd quarter valued at $34,000. 58.59% of the stock is currently owned by institutional investors.
Walgreens Boots Alliance Company Profile
(
Get Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Stories
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
